Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Checkpoint Inhibitors (ICIs)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04826406
What this trial is testing

Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).

Who this might be right for
Hepatocellular CarcinomaImmune Checkpoint Inhibitors
Hunan Cancer Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06446154
What this trial is testing

Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaImmune Checkpoint InhibitorsAnti-angiogenic Therapy+1 more
Sun Yat-sen University 36
Not applicableStudy completedNCT05688046
What this trial is testing

Efficacy and Safety Analysis of ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced NSCLC in Elderly Patients

Who this might be right for
NSCLC
Suzhou Municipal Hospital 79
Not applicableLooking for participantsNCT05718492
What this trial is testing

The Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 100
Not applicableUnknownNCT05821751
What this trial is testing

The Effect of Prebiotic Inulin on Patients Affected by R/M HNSCC Treated With Immune Checkpoint Inhibitors

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Fondazione del Piemonte per l'Oncologia 40
Not applicableStudy completedNCT04975932
What this trial is testing

Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 826
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631325
What this trial is testing

Axelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma

Who this might be right for
Unresectable Cutaneous Melanoma
John Kirkwood 28
Testing effectiveness (Phase 2)Looking for participantsNCT07811752
What this trial is testing

Sacituzumab Govitecan Combined With Tislelizumab for Locally Advanced/Metastatic Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital 28
Not applicableStudy completedNCT04566432
What this trial is testing

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

Who this might be right for
Lung NeoplasmsLung Cancer, Nonsmall CellAdenocarcinoma of Lung+1 more
Geneplus-Beijing Co. Ltd. 252
Not applicableStudy completedNCT06119347
What this trial is testing

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular Endothelial Growth Factor Monoclonal Antibody vs Immune Checkpoint Inhibitors

Who this might be right for
AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
First Affiliated Hospital of Wenzhou Medical University 1,581
Not applicableUnknownNCT04492969
What this trial is testing

Prospective Observation of Failure Patterns in NSCLC Treated With ICIs

Who this might be right for
NSCLC Stage IVNSCLC, Recurrent
Fudan University 320
Not applicableLooking for participantsNCT06950697
What this trial is testing

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Who this might be right for
Lung CancerVenous ThromboembolismArterial Thromboembolism+1 more
Beijing Chao Yang Hospital 2,400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07599111
What this trial is testing

Exploratory Study on the Efficacy and Safety of Nebulized hUC-MSC-Derived Exosomes for Non-Acute CIP

Who this might be right for
Pneumonitis, InterstitialImmune Checkpoint Inhibitors (ICIs)Mesenchymal Stem Cells+1 more
Zhou Chengzhi 40
Not applicableLooking for participantsNCT05378334
What this trial is testing

Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
Guangzhou University of Traditional Chinese Medicine 82
Not applicableWithdrawnNCT05292443
What this trial is testing

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer

Who this might be right for
Primary Liver CancerHepatocellular CarcinomaIntrahepatic Cholangiocarcinoma+1 more
Geneplus-Beijing Co. Ltd.
Testing effectiveness (Phase 2)Looking for participantsNCT06951646
What this trial is testing

CtDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)

Who this might be right for
Non Small Cell Lung CancerImmune Checkpoint Inhibitors (ICIs)
Second Xiangya Hospital of Central South University 70
Large-scale testing (Phase 3)Ended earlyNCT04985136
What this trial is testing

Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Jiangsu HengRui Medicine Co., Ltd. 1
Not applicableUnknownNCT05725915
What this trial is testing

Prediction Model of ICIs Combined With Chemotherapy in Advanced NSCLC

Who this might be right for
Lung Cancer, Nonsmall Cell
Beijing Red Clove Public Welfare Development Center 56
Not applicableUnknownNCT06518018
What this trial is testing

Efficacy and Safety of High-Dose Rate Brachytherapy With Immunotherapy and Chemotherapy as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Stage NSCLCSecond-line TreatmentPatients Without Targetable Driver Mutations
The First People's Hospital of Neijiang 80
Large-scale testing (Phase 3)UnknownNCT06031597
What this trial is testing

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Who this might be right for
Non-small Cell Lung Cancer Stage III
Zhejiang Cancer Hospital 105
Next Page